Akili Inc (AKLI)

$0.4208

Market is closed - opens 7 PM, 05 Jun 2024

Performance

  • $0.41
    $0.42
    $0.42
    downward going graph

    1.77%

    Downside

    Day's Volatility :2.31%

    Upside

    0.54%

    downward going graph
  • $0.19
    $1.67
    $0.42
    downward going graph

    54.48%

    Downside

    52 Weeks Volatility :88.55%

    Upside

    74.85%

    downward going graph

Returns

PeriodAkili Inc
3 Months
23.53%
6 Months
-11.76%
1 Year
-65.29%
3 Years
-95.8%

Highlights

Market Capitalization
33.1M
Book Value
$0.75
Earnings Per Share (EPS)
-0.62
Wall Street Target Price
0.65
Profit Margin
0.0%
Operating Margin TTM
-1551.8%
Return On Assets TTM
-35.83%
Return On Equity TTM
-70.32%
Revenue TTM
1.7M
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
574.8000000000001%
Gross Profit TTM
-118.0K
EBITDA
-64.2M
Diluted Eps TTM
-0.62
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.51
EPS Estimate Next Year
-0.46
EPS Estimate Current Quarter
-0.21
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Akili Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 54.47%

Current $0.42
Target $0.65

Company Financials

FY19Y/Y Change
Revenue
20.0M
-
Net Income
-20.6M
-
Net Profit Margin
-103.24%
-
FY20Y/Y Change
Revenue
3.9M
↓ 80.29%
Net Income
-25.6M
↑ 24.29%
Net Profit Margin
-651.08%
↓ 547.84%
FY21Y/Y Change
Revenue
538.0K
↓ 86.34%
Net Income
-61.8M
↑ 141.09%
Net Profit Margin
-11.5K%
↓ 10841.49%
FY22Y/Y Change
Revenue
323.0K
↓ 39.96%
Net Income
-8.0M
↓ 87.12%
Net Profit Margin
-2.5K%
↑ 9026.94%
FY23Y/Y Change
Revenue
1.7M
↑ 419.5%
Net Income
-59.5M
↑ 647.02%
Net Profit Margin
-3.5K%
↓ 1079.84%
Q4 FY22Q/Q Change
Revenue
111.0K
↑ 35.37%
Net Income
-16.8M
↓ 112.79%
Net Profit Margin
-15.1K%
↓ 175482.8%
Q1 FY23Q/Q Change
Revenue
113.0K
↑ 1.8%
Net Income
-22.9M
↑ 36.34%
Net Profit Margin
-20.3K%
↓ 5138.96%
Q2 FY23Q/Q Change
Revenue
114.0K
↑ 0.88%
Net Income
-11.8M
↓ 48.71%
Net Profit Margin
-10.3K%
↑ 9972.7%
Q3 FY23Q/Q Change
Revenue
702.0K
↑ 515.79%
Net Income
-15.9M
↑ 35.01%
Net Profit Margin
-2.3K%
↑ 8053.37%
Q4 FY23Q/Q Change
Revenue
749.0K
↑ 6.7%
Net Income
-11.1M
↓ 29.79%
Net Profit Margin
-1.5K%
↑ 773.29%
Q1 FY24Q/Q Change
Revenue
383.0K
↓ 48.87%
Net Income
-9.8M
↓ 12.42%
Net Profit Margin
-2.5K%
↓ 1060.84%
FY19Y/Y Change
Total Assets
43.5M
-
Total Liabilities
125.8M
-
FY20Y/Y Change
Total Assets
20.2M
↓ 53.65%
Total Liabilities
125.1M
↓ 0.56%
FY21Y/Y Change
Total Assets
80.9M
↑ 301.06%
Total Liabilities
15.2M
↓ 87.87%
FY22Y/Y Change
Total Assets
144.6M
↑ 78.6%
Total Liabilities
33.9M
↑ 123.25%
FY23Y/Y Change
Total Assets
80.4M
↓ 44.39%
Total Liabilities
21.9M
↓ 35.5%
Q4 FY22Q/Q Change
Total Assets
144.6M
↓ 12.41%
Total Liabilities
33.9M
↓ 17.7%
Q1 FY23Q/Q Change
Total Assets
124.6M
↓ 13.81%
Total Liabilities
32.2M
↓ 5.08%
Q2 FY23Q/Q Change
Total Assets
111.5M
↓ 10.54%
Total Liabilities
28.5M
↓ 11.37%
Q3 FY23Q/Q Change
Total Assets
93.1M
↓ 16.44%
Total Liabilities
24.0M
↓ 15.62%
Q4 FY23Q/Q Change
Total Assets
80.4M
↓ 13.7%
Total Liabilities
21.9M
↓ 9.14%
Q1 FY24Q/Q Change
Total Assets
67.4M
↓ 16.19%
Total Liabilities
17.2M
↓ 21.48%
FY19Y/Y Change
Operating Cash Flow
-29.4M
-
Investing Cash Flow
-461.0K
-
Financing Cash Flow
4.9M
-
FY20Y/Y Change
Operating Cash Flow
-24.6M
↓ 16.44%
Investing Cash Flow
-116.0K
↓ 74.84%
Financing Cash Flow
2.0M
↓ 59.54%
FY21Y/Y Change
Operating Cash Flow
-54.0M
↑ 119.88%
Investing Cash Flow
-492.0K
↑ 324.14%
Financing Cash Flow
112.8M
↑ 5547.9%
FY22Y/Y Change
Operating Cash Flow
-83.5M
↑ 54.72%
Investing Cash Flow
-81.2M
↑ 16407.32%
Financing Cash Flow
141.9M
↑ 25.78%
Q4 FY22Q/Q Change
Operating Cash Flow
-21.0M
↓ 1.06%
Investing Cash Flow
-14.6M
↓ 76.35%
Financing Cash Flow
-24.0K
↓ 100.02%
Q1 FY23Q/Q Change
Operating Cash Flow
-19.1M
↓ 8.88%
Investing Cash Flow
52.9M
↓ 462.9%
Financing Cash Flow
-45.0K
↑ 87.5%
Q2 FY23Q/Q Change
Operating Cash Flow
-11.6M
↓ 39.33%
Investing Cash Flow
-19.4M
↓ 136.6%
Financing Cash Flow
-647.0K
↑ 1337.78%

Technicals Summary

Sell

Neutral

Buy

Akili Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Akili Inc
Akili Inc
-0.47%
-11.76%
-65.29%
-95.8%
-95.8%
Solventum Corp
Solventum Corp
-14.04%
-19.52%
-19.52%
-19.52%
-19.52%
Veeva Systems Inc.
Veeva Systems Inc.
-15.62%
-3.68%
-11.39%
-41.19%
8.43%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-3.32%
11.22%
-4.15%
27.54%
27.54%
Healthequity Inc
Healthequity Inc
2.46%
17.68%
38.04%
-1.32%
26.95%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Akili Inc
Akili Inc
21.5
NA
NA
-0.51
-0.7
-0.36
NA
0.75
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
51.25
51.25
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
22.68
22.68
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
127.63
127.63
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Akili Inc
Akili Inc
Buy
$33.1M
-95.8%
21.5
0.0%
Solventum Corp
Solventum Corp
Hold
$10.8B
-19.52%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$28.2B
8.43%
51.25
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$35.6B
27.54%
22.68
8.05%
Healthequity Inc
Healthequity Inc
Buy
$7.1B
26.95%
127.63
5.57%

Institutional Holdings

  • Social Capital Group LLC

    15.09%

  • Temasek Holdings Ltd.

    14.63%

  • Neuberger Berman Group LLC

    7.34%

  • Baillie Gifford & Co Limited.

    5.93%

  • Suvretta Capital Management, LLC

    4.88%

  • Comprehensive Financial Management LLC

    1.35%

Company Information

Organization
Akili Inc
Employees
68
CEO
Dr. Walter Edward Martucci II, Ph.D.
Industry
Financial

Discover More

FAQs